Tech Company Financing Transactions

Qlaris Bio Funding Round

Canaan Partners, New Leaf Venture Partners and Abrdn participated in a $24 million Series B funding round for Qlaris Bio. This VC investment round was recorded on 4/30/2024.

Transaction Overview

Company Name
Announced On
4/30/2024
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to support the continued clinical development of QLS-111, a first-in-class therapeutic being developed to lower intraocular pressure (IOP) by targeting episcleral venous pressure (EVP).

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
770 Legacy Place, 2nd Floor
Dedham, MA 02026
USA
Phone
Undisclosed
Email Address
Overview
Qlaris was founded upon a singular concept--that a comprehensive and complementary approach combining all aspects of scientific, medical, business, and strategic considerations can lead to unique insights enabling creative new ways to unlock value for patients suffering from debilitating ophthalmic diseases.
Profile
Qlaris Bio LinkedIn Company Profile
Social Media
Qlaris Bio Company Twitter Account
Company News
Qlaris Bio News
Facebook
Qlaris Bio on Facebook
YouTube
Qlaris Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thurein Htoo
  Thurein Htoo LinkedIn Profile  Thurein Htoo Twitter Account  Thurein Htoo News  Thurein Htoo on Facebook
Chief Medical Officer
Barbara Wirostko
  Barbara Wirostko LinkedIn Profile  Barbara Wirostko Twitter Account  Barbara Wirostko News  Barbara Wirostko on Facebook
VP - Manufacturing
Ralph Casale
  Ralph Casale LinkedIn Profile  Ralph Casale Twitter Account  Ralph Casale News  Ralph Casale on Facebook
VP - Operations
Lisa Brandano
  Lisa Brandano LinkedIn Profile  Lisa Brandano Twitter Account  Lisa Brandano News  Lisa Brandano on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/30/2024: PsiQuantum venture capital transaction
Next: 4/30/2024: Integrity Orthopaedics venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary